SNTI Company Profile and Key Details
Senti Biosciences, Inc.
SNTI Stock Price Chart
Stock Price Today
Senti Biosciences, Inc. (SNTI) stock declined over -1.36%, trading at $4.36 on NASDAQ, down from the previous close of $4.42. The stock opened at $4.55, fluctuating between $4.35 and $4.56 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells to target particularly challenging liquid and solid tumor oncology indications. The company's lead programs include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate acute myeloid leukemia (AML) cells, while sparing the healthy bone marrow; and SENTI-301, a multi-armed off-the-shelf CAR-NK cell therapy designed for the treatment of hepatocellular carcinoma (HCC). It also develops SENTI-401, a Logic Gated (NOT) off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer (CRC) cells, while sparing healthy cells in the body. The company was founded in 2016 and is based in South San Francisco, California.
Company Information
| Employees | 48 |
| Beta | 2.75 |
| Sales or Revenue | $2.56M |
| 5Y Sales Change% | 91.257% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Senti Biosciences, Inc. (NASDAQ: SNTI) stock price is $4.36 in the last trading session. During the trading session, SNTI stock reached the peak price of $4.56 while $4.35 was the lowest point it dropped to. The percentage change in SNTI stock occurred in the recent session was -1.36% while the dollar amount for the price change in SNTI stock was -$0.06.
The NASDAQ listed SNTI is part of Biotechnology industry that operates in the broader Healthcare sector. Senti Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Philip Lee Ph.D.
Co-Founder & Chief Technology Officer
Ms. Susan D. Berland
Senior Financial Executive & Independent Director
Dr. Kanya Rajangam M.D., Ph.D.
Head of R&D and Chief Medical Officer
Susan Kahlert
Controller
Dr. Deborah A. Knobelman Ph.D.
Chief Financial Officer & Treasurer
Dr. Wilson Wong Ph.D.
Scientific Co-Founder & Member of Scientific Advisory Board
Dr. Timothy K. Lu M.D., Ph.D.
Scientific Founder
Dr. James J. Collins Ph.D.
Co-Founder & Member of Scientific Advisory Board
SNTI's closing price is 186.84% higher than its 52-week low of $1.52 where as its distance from 52-week high of $16.94 is -74.26%.
Number of SNTI employees currently stands at 48.
Official Website of SNTI is: https://www.sentibio.com
SNTI could be contacted at phone 650 382 3281 and can also be accessed through its website. SNTI operates from 2 Corporate Drive, South San Francisco, CA 94080, United States.
SNTI stock volume for the day was 15.48K shares. The average number of SNTI shares traded daily for last 3 months was 2.43M.
The market value of SNTI currently stands at $21.06M with its latest stock price at $4.36 and 4.83M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com